In the current study, we investigated the expression of BRAF V600E mutations in a CRC cohort of 571 patients using a novel extendable blocking probe reverse transcriptase (ExBP‐RT) assay that we recently developed. This evidence concerns the gene BRAF and colorectal carcinoma.